The non-toxic A subunit of Shiga toxin type 1 prevents replication of bovine immunodeficiency virus in infected cells

被引:13
作者
Ferens, Witold A. [1 ]
Hovde, Carolyn J. [1 ]
机构
[1] Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83844 USA
关键词
antiviral; bovine immunodeficiency virus; Shiga toxin;
D O I
10.1016/j.virusres.2006.12.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Shiga toxins are ribosome-inactivating proteins many of which are antiviral. Shiga toxin-producing Escherichia coli (STEC) may be pathogenic to humans, but are carried without ill effects by ruminants. We hypothesize that STEC have antiviral activity in ruminants, and showed previously that the non-toxic subunit A of Shiga toxin 1 (StxA1) acts selectively on cells infected with bovine leukemia virus, without harming normal cells, and that the numbers of intestinal STEC are inversely correlated with viral load in bovine leukemia virus-infected sheep. The purpose of the present study was to characterize StxA1 activity against a second bovine retrovirus, bovine immunodeficiency virus (BIV). Flow cytometry showed that StxA1 treatment induced apoptosis in BIV-infected cells but not in uninfected cells and immunoblot analysis showed that StxA1 curtailed synthesis of Gag p26 protein. A systematic electron microscopy description of BIV infection in fetal bovine lung fibroblasts showed an orderly sequence of changes in cell membrane, endoplasmic reticulum, Golgi, nucleus, and mitochondria, and suggested that the infected cells produce the virus within multivesicular bodies (MVBs). StxA1 interfered with all manifestations of BIV-induced transformation of infected cells into BIV-producing units. BIV-infected cells provided a suitable experimental system for investigation of the mechanism of Stx-antiviral activity. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 41
页数:13
相关论文
共 56 条
[1]   EFFECT OF INTERFERON ON THE FORMATION AND RELEASE OF INTRACELLULAR VIRIONS IN NIH 3T3 CELLS CHRONICALLY INFECTED WITH MOLONEY MURINE LEUKEMIA-VIRUS [J].
ABOUD, M ;
MALIK, Z ;
BARI, S ;
KIMCHI, R ;
HASSAN, Y ;
SALZBERG, S .
JOURNAL OF INTERFERON RESEARCH, 1983, 3 (01) :33-44
[2]   CYTOTOXICITY OF A SHIGA TOXIN-A SUBUNIT-CD4 FUSION PROTEIN TO HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS [J].
ALJAUFY, AY ;
HADDAD, JE ;
KING, SR ;
MCPHEE, RA ;
JACKSON, MP .
INFECTION AND IMMUNITY, 1994, 62 (03) :956-960
[3]   Detection and genetical characterization of shiga toxin-producing Escherichia coli from wild deer [J].
Asakura, H ;
Makino, S ;
Shirahata, T ;
Tsukamoto, T ;
Kurazono, H ;
Ikeda, T ;
Takeshi, K .
MICROBIOLOGY AND IMMUNOLOGY, 1998, 42 (12) :815-822
[4]   The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase [J].
Au, TK ;
Collins, RA ;
Lam, TL ;
Ng, TB ;
Fong, WP ;
Wan, DCC .
FEBS LETTERS, 2000, 471 (2-3) :169-172
[5]   TRANSFORMATION OF CELLS BY ROUS-SARCOMA VIRUS - CYTOPLASMIC VACUOLIZATION [J].
BADER, AV ;
BADER, JP .
JOURNAL OF CELLULAR PHYSIOLOGY, 1976, 87 (01) :33-46
[6]   THE BOVINE IMMUNODEFICIENCY-LIKE VIRUS (BIV) IS TRANSCRIPTIONALLY ACTIVE IN EXPERIMENTALLY INFECTED CALVES [J].
BARON, T ;
MALLET, F ;
POLACK, B ;
BETEMPS, D ;
BELLI, P .
ARCHIVES OF VIROLOGY, 1995, 140 (08) :1461-1467
[7]   Antiviral activity of Shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells [J].
Basu, I ;
Ferens, WA ;
Stone, DM ;
Hovde, CJ .
INFECTION AND IMMUNITY, 2003, 71 (01) :327-334
[8]   PREVALENCE AND SOME PROPERTIES OF VEROTOXIN (SHIGA-LIKE TOXIN)-PRODUCING ESCHERICHIA-COLI IN 7 DIFFERENT SPECIES OF HEALTHY DOMESTIC-ANIMALS [J].
BEUTIN, L ;
GEIER, D ;
STEINRUCK, H ;
ZIMMERMANN, S ;
SCHEUTZ, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (09) :2483-2488
[9]  
BISHOP SA, 1993, CLIN EXP IMMUNOL, V93, P65
[10]   INTERFERON-GAMMA INDUCES THE EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERSISTENTLY INFECTED PROMONOCYTIC CELLS (U1) AND REDIRECTS THE PRODUCTION OF VIRIONS TO INTRACYTOPLASMIC VACUOLES IN PHORBOL-MYRISTATE ACETATE DIFFERENTIATED U1 CELLS [J].
BISWAS, P ;
POLI, G ;
KINTER, AL ;
JUSTEMENT, JS ;
STANLEY, SK ;
MAURY, WJ ;
BRESSLER, P ;
ORENSTEIN, JM ;
FAUCI, AS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (03) :739-750